Matrix-Bio, Inc. Information

View Top Employees from Matrix-Bio, Inc.

Matrix-Bio's goal is to be a leading provider of metabolomics-based testing in the fast-growing molecular diagnostic testing market. The company's first product, VeraMarker™ BCR, a blood test for detecting breast cancer and cancer recurrence monitoring, is being commercialized as the first metabolite-based test in the world. Matrix-Bio is currently exploring the commercial feasibility of additional diagnostics tests using its VeraMarker technology platform, including colon, esophageal, liver and pancreatic cancer; for identifying liver cancer in patients with hepatitis C; and for predicting preoperative chemotherapy effectiveness for breast cancer treatment.

Website	http://www.matrix-bio.com
Revenue	$3 million
Employees	2 (1 on RocketReach)
Founded	2009
Address	10351 Dawson’s Creek Blvd. Suite D, Fort Wayne, Indiana 47825, US
Phone	+1 260-387-7540
Technologies	JavaScript , HTML , PHP +9 more (view full list)
Industry	Biotechnology, Biotechnology Research, Medical Testing & Clinical Laboratories, Metabolite Profiling, Healthcare, Science and Engineering, Drug Discovery, Molecular Diagnostic Testing, Pharmaceutical, Cancer Detection, Health Care, Cancer Recurrence Monitoring
Keywords	Molecular Diagnostics, Cancer Detection, Breast Cancer, Biomarker Discovery, Diagnostic Testing, Precision Medicine, Liquid Biopsy, Early Cancer Detection, Oncology Testing, Molecular Profiling, Clinical Diagnostics, Cancer Monitoring, Biomarker Validation, Diagnostic Tools, Healthcare Technology, Medical Diagnostics, Health Diagnostics
Competitors	Natera, Exact Sciences, Guardant Health, GRAIL, Myriad Genetics, Foundation Medicine, Invitae, Freenome, PathAI, carisls +30 more (view full list)
SIC	SIC Code 807 Companies, SIC Code 80 Companies
NAICS	NAICS Code 621 Companies, NAICS Code 62151 Companies, NAICS Code 6215 Companies, NAICS Code 62 Companies